Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Benjamin L. Ebert, M.D., D.Phil.

Co-Author

This page shows the publications co-authored by Benjamin Ebert and Adam Sperling.
Connection Strength

5.455
  1. CHIPing Away at Breast Cancer. J Natl Cancer Inst. 2020 01 01; 112(1):10-11.
    View in: PubMed
    Score: 0.907
  2. Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs. Blood. 2019 07 11; 134(2):160-170.
    View in: PubMed
    Score: 0.866
  3. Prevalent premalignancy. Blood. 2017 08 10; 130(6):695-696.
    View in: PubMed
    Score: 0.768
  4. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017 01; 17(1):5-19.
    View in: PubMed
    Score: 0.729
  5. Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide. Nat Rev Clin Oncol. 2021 Mar 02.
    View in: PubMed
    Score: 0.246
  6. Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide. Sci Transl Med. 2021 Jan 06; 13(575).
    View in: PubMed
    Score: 0.243
  7. Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis. Blood. 2020 12 24; 136(26):3051-3055.
    View in: PubMed
    Score: 0.243
  8. Small-molecule-induced polymerization triggers degradation of BCL6. Nature. 2020 12; 588(7836):164-168.
    View in: PubMed
    Score: 0.241
  9. Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint Blockade. JCO Precis Oncol. 2020; 4.
    View in: PubMed
    Score: 0.238
  10. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. Nature. 2020 09; 585(7824):293-297.
    View in: PubMed
    Score: 0.233
  11. Identification of germline variants in adults with hemophagocytic lymphohistiocytosis. Blood Adv. 2020 03 10; 4(5):925-929.
    View in: PubMed
    Score: 0.230
  12. Myelodysplastic syndromes (MDS) occurring in Agent Orange exposed individuals carry a mutational spectrum similar to that of de novo MDS. Leuk Lymphoma. 2020 03; 61(3):728-731.
    View in: PubMed
    Score: 0.225
  13. Modeling and targeting of erythroleukemia by hematopoietic genome editing. Blood. 2021 Mar 25; 137(12):1628-1640.
    View in: PubMed
    Score: 0.062
  14. A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade. Haematologica. 2021 02 01; 106(2):651-654.
    View in: PubMed
    Score: 0.061
  15. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nat Commun. 2020 06 12; 11(1):2996.
    View in: PubMed
    Score: 0.058
  16. Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy. Am J Hematol. 2020 03; 95(3):245-250.
    View in: PubMed
    Score: 0.057
  17. A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia. Am J Hematol. 2018 02; 93(2):254-261.
    View in: PubMed
    Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.